Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21732834 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV
Conditions: HIV Infection;   Tuberculosis;   Pneumocystis Jiroveci Pneumonia
Interventions: Drug: Isoniazid (INH);   Drug: Trimethoprim/Sulfamethoxazole (TMP/SMX);   Drug: Isoniazid Placebo (PL)

Indicates status has not been verified in more than two years